Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Artificial heart research

This article was originally published in The Gray Sheet

Executive Summary

National Heart, Lung, and Blood Institute awards three contracts for development of a total artificial heart and for evaluation of its compatibility with body tissues. Three teams -- Abiomed and the Texas Heart Institute; Nimbus, Inc. and the Cleveland Clinic Foundation; and Pennsylvania State University and Sarns/3M Health Care -- will each receive between $5 mil. and $6 mil. over a three-year Phase I period. The University of Utah, one of the NHLBI developers until now ("The Gray Sheet, May 25, 1992, I&W-8), did not receive additional funding. NHLBI says the two most promising artificial hearts will be selected to proceed to Phase II, for which funding would range between $8 mil. and $9 mil. over four years.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT001248

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel